Lupin Pharma partners with Endoceutics to commercialise Intrarosa in Canada

Intrarosa is Endoceutic's flagship product indicated for the treatment of postmenopausal vulvovaginal atrophy.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3vanlD8
via IFTTT